BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 36050469)

  • 1. NRF2 mediates melanoma addiction to GCDH by modulating apoptotic signalling.
    Verma S; Crawford D; Khateb A; Feng Y; Sergienko E; Pathria G; Ma CT; Olson SH; Scott D; Murad R; Ruppin E; Jackson M; Ronai ZA
    Nat Cell Biol; 2022 Sep; 24(9):1422-1432. PubMed ID: 36050469
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Elevated glutaric acid levels in Dhtkd1-/Gcdh- double knockout mice challenge our current understanding of lysine metabolism.
    Biagosch C; Ediga RD; Hensler SV; Faerberboeck M; Kuehn R; Wurst W; Meitinger T; Kölker S; Sauer S; Prokisch H
    Biochim Biophys Acta Mol Basis Dis; 2017 Sep; 1863(9):2220-2228. PubMed ID: 28545977
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The first knock-in rat model for glutaric aciduria type I allows further insights into pathophysiology in brain and periphery.
    Gonzalez Melo M; Remacle N; Cudré-Cung HP; Roux C; Poms M; Cudalbu C; Barroso M; Gersting SW; Feichtinger RG; Mayr JA; Costanzo M; Caterino M; Ruoppolo M; Rüfenacht V; Häberle J; Braissant O; Ballhausen D
    Mol Genet Metab; 2021 Jun; 133(2):157-181. PubMed ID: 33965309
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Striatal neuronal death mediated by astrocytes from the Gcdh-/- mouse model of glutaric acidemia type I.
    Olivera-Bravo S; Ribeiro CA; Isasi E; Trías E; Leipnitz G; Díaz-Amarilla P; Woontner M; Beck C; Goodman SI; Souza D; Wajner M; Barbeito L
    Hum Mol Genet; 2015 Aug; 24(16):4504-15. PubMed ID: 25968119
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oxidative Stress, Disrupted Energy Metabolism, and Altered Signaling Pathways in Glutaryl-CoA Dehydrogenase Knockout Mice: Potential Implications of Quinolinic Acid Toxicity in the Neuropathology of Glutaric Acidemia Type I.
    Seminotti B; Amaral AU; Ribeiro RT; Rodrigues MDN; Colín-González AL; Leipnitz G; Santamaría A; Wajner M
    Mol Neurobiol; 2016 Nov; 53(9):6459-6475. PubMed ID: 26607633
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Disease-causing mutations affecting surface residues of mitochondrial glutaryl-CoA dehydrogenase impair stability, heteromeric complex formation and mitochondria architecture.
    Schmiesing J; Lohmöller B; Schweizer M; Tidow H; Gersting SW; Muntau AC; Braulke T; Mühlhausen C
    Hum Mol Genet; 2017 Feb; 26(3):538-551. PubMed ID: 28062662
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impairment of GABAergic system contributes to epileptogenesis in glutaric acidemia type I.
    Vendramin Pasquetti M; Meier L; Loureiro S; Ganzella M; Junges B; Barbieri Caus L; Umpierrez Amaral A; Koeller DM; Goodman S; Woontner M; Gomes de Souza DO; Wajner M; Calcagnotto ME
    Epilepsia; 2017 Oct; 58(10):1771-1781. PubMed ID: 28762469
    [TBL] [Abstract][Full Text] [Related]  

  • 8. DHTKD1 and OGDH display substrate overlap in cultured cells and form a hybrid 2-oxo acid dehydrogenase complex in vivo.
    Leandro J; Dodatko T; Aten J; Nemeria NS; Zhang X; Jordan F; Hendrickson RC; Sanchez R; Yu C; DeVita RJ; Houten SM
    Hum Mol Genet; 2020 May; 29(7):1168-1179. PubMed ID: 32160276
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Multifactorial modulation of susceptibility to l-lysine in an animal model of glutaric aciduria type I.
    Sauer SW; Opp S; Komatsuzaki S; Blank AE; Mittelbronn M; Burgard P; Koeller DM; Okun JG; Kölker S
    Biochim Biophys Acta; 2015 May; 1852(5):768-77. PubMed ID: 25558815
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Deglutarylation of glutaryl-CoA dehydrogenase by deacylating enzyme SIRT5 promotes lysine oxidation in mice.
    Bhatt DP; Mills CA; Anderson KA; Henriques BJ; Lucas TG; Francisco S; Liu J; Ilkayeva OR; Adams AE; Kulkarni SR; Backos DS; Major MB; Grimsrud PA; Gomes CM; Hirschey MD
    J Biol Chem; 2022 Apr; 298(4):101723. PubMed ID: 35157847
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Heterozygosity for an in-frame deletion causes glutaryl-CoA dehydrogenase deficiency in a patient detected by newborn screening: investigation of the effect of the mutant allele.
    Bross P; Frederiksen JB; Bie AS; Hansen J; Palmfeldt J; Nielsen MN; Duno M; Lund AM; Christensen E
    J Inherit Metab Dis; 2012 Sep; 35(5):787-96. PubMed ID: 22231382
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of targeted suppression of glutaryl-CoA dehydrogenase by lentivirus-mediated shRNA and excessive intake of lysine on apoptosis in rat striatal neurons.
    Gao J; Zhang C; Fu X; Yi Q; Tian F; Ning Q; Luo X
    PLoS One; 2013; 8(5):e63084. PubMed ID: 23658800
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Marked reduction of Na(+), K(+)-ATPase and creatine kinase activities induced by acute lysine administration in glutaryl-CoA dehydrogenase deficient mice.
    Amaral AU; Cecatto C; Seminotti B; Zanatta Â; Fernandes CG; Busanello EN; Braga LM; Ribeiro CA; de Souza DO; Woontner M; Koeller DM; Goodman S; Wajner M
    Mol Genet Metab; 2012 Sep; 107(1-2):81-6. PubMed ID: 22578804
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Experimental evidence that bioenergetics disruption is not mainly involved in the brain injury of glutaryl-CoA dehydrogenase deficient mice submitted to lysine overload.
    Amaral AU; Cecatto C; Seminotti B; Ribeiro CA; Lagranha VL; Pereira CC; de Oliveira FH; de Souza DG; Goodman S; Woontner M; Wajner M
    Brain Res; 2015 Sep; 1620():116-29. PubMed ID: 25998543
    [TBL] [Abstract][Full Text] [Related]  

  • 15. l-Carnitine prevents oxidative stress in striatum of glutaryl-CoA dehydrogenase deficient mice submitted to lysine overload.
    Guerreiro G; Amaral AU; Ribeiro RT; Faverzani J; Groehs AC; Sitta A; Deon M; Wajner M; Vargas CR
    Biochim Biophys Acta Mol Basis Dis; 2019 Sep; 1865(9):2420-2427. PubMed ID: 31181292
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Disturbance of the glutamatergic system by glutaric acid in striatum and cerebral cortex of glutaryl-CoA dehydrogenase-deficient knockout mice: possible implications for the neuropathology of glutaric acidemia type I.
    Busanello EN; Fernandes CG; Martell RV; Lobato VG; Goodman S; Woontner M; de Souza DO; Wajner M
    J Neurol Sci; 2014 Nov; 346(1-2):260-7. PubMed ID: 25241940
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reduction of Na+, K+-ATPase activity and expression in cerebral cortex of glutaryl-CoA dehydrogenase deficient mice: a possible mechanism for brain injury in glutaric aciduria type I.
    Amaral AU; Seminotti B; Cecatto C; Fernandes CG; Busanello EN; Zanatta Â; Kist LW; Bogo MR; de Souza DO; Woontner M; Goodman S; Koeller DM; Wajner M
    Mol Genet Metab; 2012 Nov; 107(3):375-82. PubMed ID: 22999741
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Potential complementation effects of two disease-associated mutations in tetrameric glutaryl-CoA dehydrogenase is due to inter subunit stability-activity counterbalance.
    Ribeiro JV; Lucas TG; Bross P; Gomes CM; Henriques BJ
    Biochim Biophys Acta Proteins Proteom; 2020 Jan; 1868(1):140269. PubMed ID: 31491587
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Induction of Neuroinflammatory Response and Histopathological Alterations Caused by Quinolinic Acid Administration in the Striatum of Glutaryl-CoA Dehydrogenase Deficient Mice.
    Amaral AU; Seminotti B; da Silva JC; de Oliveira FH; Ribeiro RT; Vargas CR; Leipnitz G; Santamaría A; Souza DO; Wajner M
    Neurotox Res; 2018 Apr; 33(3):593-606. PubMed ID: 29235064
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Disease-Linked Glutarylation Impairs Function and Interactions of Mitochondrial Proteins and Contributes to Mitochondrial Heterogeneity.
    Schmiesing J; Storch S; Dörfler AC; Schweizer M; Makrypidi-Fraune G; Thelen M; Sylvester M; Gieselmann V; Meyer-Schwesinger C; Koch-Nolte F; Tidow H; Mühlhausen C; Waheed A; Sly WS; Braulke T
    Cell Rep; 2018 Sep; 24(11):2946-2956. PubMed ID: 30208319
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.